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A lymphoproliferative response occurs in the regional lymph node after stimu- 
lation with sheep  red blood cells (SRBC)3  The  rate of  cell division increases 
for a  period of 4  days and then rapidly subsides (1).  One product of this pro- 
liferative response is a  poorly sustained state of delayed-type hypersensitivity 
(DTH)  which  is  mediated  by  0-bearing  lymphocytes  (1),  but  animals  once 
stimulated  to  respond  in  this  way  become  refractory  and  cannot  again  be 
rendered hypersensitive (2). This impediment to the reinduction of DTH is not 
easily overcome; even Freund's complete adjuvant may fail to establish DTH 
in previously immunized animals, a  phenomenon  known  as immune deviation 
(3).  A  mechanism  which  obstructs  or  terminates  a  T-cell response,  or which 
otherwise  interferes  with  the  functional  activities  of  specifically  sensitized 
lymphocytes, is of  obvious importance in  transplantation,  antimicrobial, and 
antitumor immunity because the implementation of these forms of immunity 
depends (in varying degree) upon the T-cell component of the immune response. 
The present report deals with the mechanism that regulates T-cell activity in 
animals  which  have  been  immunized  without  the  adjuvants  or  selective  im- 
munosuppressants that are commonly used to induce a  state of DTH. 
Materials and Methods 
Animals.--Male  and female  mice  of the CD-1  strain  (Charles  River Breeding  Labora- 
tories, Inc., Wilmington, Mass.), from  a specific pathogen-free colony, were used at 5 or 6 
wk of age. 
Antigens.--SRBC  were  obtained  twice  weekly,  always  from  the  same  animal.  Cells 
collected and stored in Alsever's solution were washed three times with normal saline and sus- 
pended to a known density by hemocytometer count. 
Serum.--Bleeding  was performed  by heart puncture of ether-anesthetized mice. Bleedings 
were pooled  or handled individually. Mter clotting the serum  was  separated, sterilized by 
membrane filtration, and stored at --20°C.  It was inactivated before use by heating for 30 
rain at 56°C. 
Antibody  Titration.--Hemagglutinin  titers were determined in microtitration trays using 
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0.1 ml vol of serum diluted serially in isotonic Veronal buffer (4), to which was added an equal 
volume of 1% packed SRBC. After 30 rain at 37°C the trays stood overnight at 4°C. Mer- 
captoethanol-resistant  antibody titers  were determined  in the same way with serum which 
had been reduced for 1/~ h at room temperature with mercaptoethanol at a final concentration 
of 0.1 M (5). 
Other Techniques.--Descripfions have been given of the methods  used for measuring de- 
layed-type hypersensitivity  in the footpad (1), the lymphoproliferafive response in a regional 
lymph node (6), and the number of plaque-forming cells (PFC)  that appear in the popliteal 
lymph node following footpad inoculation with SRBC (1). The procedure for adoptive sensi- 
tization by spleen cell transfer has also been described (7). 
RESULTS 
It was shown in the preceding paper (2) that the induction of DTH by intra- 
venous  immunization  with  SRBC  is  critically dependent  upon  antigen  dose. 
Fig. 1 depicts the results of an experiment in which the total  hemagglutinating 
activity of the serum and corresponding levels of DTH were measured on day 4 
in mice which had been immunized intravenously with varying doses  of SRBC. 
As in the preceding study, the peak level of DTH was achieved with a dose  of 
105 SRBC; but  hemagglutinins  could not be detected  in the pooled se~um  of 
mice immunized with this dose of red cells,  and were scarcely detectable  after 
a  dose of 106. They appeared  in increasing  amounts,  however,  as  the  dose  of 
SRBC  was increased above this  threshold,  and as they increased,  the level  of 
DTH  decreased  proportionally.  This  inverse  relationship  between  antibody 
titer and prevailing level of DTH points to a direct inhibitory effect of antibody 
on the production or function of specifically sensitized lymphocytes. A  role for 
antibody in  suppressing  the  development  of DTH  had  been  suspected  when 
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FIG. 1. Mean levels of DTH measured on day 4 (O-- -0), and of hemagglutinin fiter 
(A---A) in pooled serum, also obtained on day 4, from mi.'e immunized intravenously with 
the indicated doses of SRBC. Means of 5. MACKANESS, LAGRANGE, MILLER, AND  ISHIBASHI  545 
splenectomized animals, which produce  little  or no  antibody in  response  to 
intravenous immunization (8), became hypersensitive with doses of SRBC that 
were too big to sensitize intact mice (2). 
Since the antibodies measured during the initial phase  of the immune re- 
sponse (Fig. 1) were completely sensitive to mercaptoethanol it seemed that the 
induction of T  cells  might be  inhibited by specific  IgM  antibodies.  It  was 
equally possible, however, that activated T cells are formed but cannot function 
in the presence of large amounts of antigen. Since DTH to SRBC can be trans- 
ferred adoptively with spleen cells (1), the immunological status of the activated 
T  cells produced in response to high and low doses of antigen could be tested 
directly. Two experiments were performed: In the first, spleen cells were trans- 
ferred to normal recipients from donors which had been sensitized or blocked 
with doses of 10  5 and 10  9 SRBC, respectively; in the second experiment, spleen 
cells were transferred from highly sensitive donors into anergic recipients which 
had themselves been immunized 4 days previously with the larger (10  9) dose of 
SRBC. 
Fig. 2 A shows what levels of DTH to expect in recipients of a given number 
of spleen cells from sensitized donors. The recipients of 2  X  10  s spleen cells 
(one spleen equivalent) commonly react with about half the level of DTH dis- 
played by the donors (Fig. 2 A). But whereas one spleenequivalent (2  >(  10  8) 
of cells from reactive donors conferred the expected levels of DTH upon normal 
recipients, twice that number of spleen cells from donors rendered anergic by 
an intravenous injection of 10  9 SRBC did not make normal recipients hyper- 
sensitive (Fig. 2 B); and animals in the same anergic state failed to react after 
receiving cells from highly sensitive donors (Fig. 2 C). The latter finding con- 
firms the observations of Dwyer and Kantor (9) who showed that DTH cannot 
be conferred upon sensitized animals in which hypersensitivity had been sup- 
pressed by a desensitizing dose of soluble antigen. But, in apparent contradic- 
tion of Dwyer and Kantor, the cells of spontaneously nonreactive donors (as 
opposed to the desensitized donors of their experiments) failed to transfer re- 
activity adoptively. A single large dose of SRBC, lying within the range of doses 
that gives an optimal antibody response (10),  thus blocked the expression of 
both actively and adoptively acquired DTH. 
Radovich and Talmage (11) had  raised  the  possibility, in  connection with 
the phenomenon of antigenic competition, that blocking of the second immune 
response is due to a humoral product of the first. The fact that footpad sensiti- 
zation could not be achieved once SRBC had been injected intravenously (2) 
suggested that the block might be located at the level of T-cell induction. The 
question was not a trivial one because Diener and Feldmann (12) had concluded 
that the control of antibody production is exercised through B cells rather than 
T cells. To investigate this question, serum was obtained on day 4 from animals 
which had been immunized intravenously with a  large  (10  9) blocking dose of 
SRBC.  This  day was  chosen for bleeding  because  it  marks  the  end  of  the 
lymphoproliferative response to SRBC in regionally stimulated nodes (1)  and 546  FEEDBACK  INtIIBITION  OF  SENSITIZED  LYMPHOCYTES 
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FIG. 2.  (A) Levels of DTH to SRBC  in donors  (D) which were immunized  in one hind 
footpad after priming with BCG, and in adoptively sensitized  recipients (©) given varying 
numbers of spleen cells from  the donor panel. The control animals (on the fight)  received 
spleen cells from donors given BCG only. (B) Transfer of DTH with spleen cells (2 X 10 8) from 
hypersensitive donors  (black columns)  which  had been immunized  with  10 5 SRBC  intra- 
venously. The recipients showed the expected level of DTH (white column). Recipients of 4 X 
10 8 spleen cells from  anergic donors which were immunized  intravenously with 10 9 SRBC 
were not sensitive.  Means of 5 :E SE.  (C) Anergic recipients (b]ocked by 10 9 SRBC  intra- 
venously) were not rendered hypersensitive with 2 X  l0 s spleen cells from the same panel of 
donors used in A  (IR), but another group of normal recipients (NR) were. Controls  (C) were 
untreated. Means of 5 4- SE. 
because I)TH  declines rapidly from  its peak  on  this  day  (2).  Both  of  these 
findings suggested that blocking activity, if it existed in the serum,  would be 
most  readily detected in serum  taken  at this time. 
Immune  serum, drawn on day 4  of the immune response, hereafter referred 
to as $4, was tested for blocking activity in four groups of mice which had been 
immunized by a  footpad injection of l0  s SRBC, a  highly sensitizing dose when 
given by this route  (2).  Mice of two  groups were  treated intravenously with 
0.5 ml of $4, mice of one group being injected at the time of sensitization, the 
others  12  h  earlier. A  third  group  of sensitized controls received serum  from 
normal  donors,  also  given  at  the  time  of  sensitization,  and  a  fourth  group 
served  as  sensitized but  untreated  controls.  When  tests  for  DTH  were  per- 
formed 4  days later unsensitized controls were also included. The observations 
recorded in Fig. 3  shows that the induction of DTH  was partially suppressed 
when $4 was given immediately before the sensitizing dose of SRBC and more 
so in animals treated 12 h  earlier. 
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FIG. 3. The effect of an intravenous injection of 4 day immune serum (0.5 ml) on the in- 
duction of DTH by a sensitizing dose of SRBC (10 s) given in one hind footpad. Untreated 
controls (group A) and recipients of normal mouse serum (group B) developed DTH in the 
usual way. Animals given immune serum immediately before (group C) or 12 h before sensi- 
tization (group D) were partially suppressed. Unsensifized controls (group E) did not react, 
Means of 5 4- SE. 
major portion  of  the  inoculum  used  in  the  foregoing  experiment  had  been 
destroyed in nonimmunological organs as the liver. Although diversion, neutra- 
lization, or destruction of antigen by specific antibody seemed unlikely explana- 
tions  for  the  inhibitory  effect  that  immune  serum  had  on  the  induction  of 
DTH, it was nonetheless important to establish whether antibody as such can 
affect the antigenicity of SRBC. If antigenicity were reduced by opsonization a 
larger dose of opsonized SRBC would be required to achieve maximum DTH 
and the dose-response curve of Fig. 1 would be shifted to the right. SRBC were 
therefore treated with normal or immune serum ($4) by adding packed SRBC 
to whole serum in a ratio of 1 : 10. The cells were mixed and allowed to stand for 
15 min at room temperature. After centrifugation the supernatant serum was 
decanted  and  the  opsonized  red  cells  were  washed  three  times  with  normal 
saline at 4°C. Tests for opsonization were then performed by injecting samples 
of each cell suspension (5 X  107 in 0.1 ml) into the peritoneal cavity. Cells were 
recovered 1 and 3 h  later by introducing  2.5  ml of heparinized saline through 
the abdominal wall of three mice from each group, at each time point. The total 
numbers  of  extracellular  SRBC  in  the  washings  were  counted  directly  in  a 
hemocytometer, and are recorded in Table I. In addition,  samples of the  cells 
washed from the peritoneal cavity were deposited on slides with a cytocentri- 
fuge (Fig. 4). 
As indicated in Table I, and illustrated  in Fig.  4,  red cells were effectively 548  FEEDBACK  INHIBITION OF  SENSITIZED LYMPHOCYTES 
TABLE I 
Total and Mean Numbers of SRBC in the Extra Cellular Phase 1 and 3 h after Intraperitoneal 
Injection of Red Cells Treated with Normal or 4-Day Immune Serum*~ 
lh  3h 
Mouse 
Unopsonized  Opsonized  Unopsonizcd  Opsonlzed 
1  5.1  X  107  2.5  X  106  3.0  X  106  5  X  104 
2  4.8  X  l0 T  2.0  X  106  2.2  X  106  1 X  105 
3  6.3  X  107  1.2  X  106  6.5  X  106  4  X  104 
Mean  5.4  X  107  1.9  X  106  3.9  X  106  3.3  X  104 
% ingested  0 §  96.2  92.2  99.94 
* Inoculum: 0.1  ml containing 5  X  107 SRBC. 
Washout:  2.5  ml Hanks' BSS containing 5 intravenous heparin/ml. 
§ Assuming no loss of SRBC by lymphatic drainage from the peritoneal cavity. 
opsonized by exposure to $4, phagocytosis of S4-treated SRBC being virtually 
complete  within  1  h  of  injection  into  the  peritoneal  cavity.  The  opsonized 
SRBC were apparently no more or less immunogenic, however, for the numbers 
needed  to produce maximum DTH were the same for normal  and opsonized 
cells (Fig. 5 A). Even if a larger proportion of the opsonized SRBC had been 
diverted  to highly phagocytic organs,  such  as the liver,  the process of T-cell 
activation in the spleen, where the response to SRBC is centered (2), was ob- 
viously unaffected. This is not surprising in light of Wason's observation (13) 
showing that antibody-treated SRBC  reach the spleen with  added  efficiency. 
Although opsonization did not seem to alter the anfigenicity of SRBC,  the 
possibility remained that antibody might be capable of inhibiting DTH in other 
ways. This possibility was tested with the supernatant  serum remaining after 
opsonization.  It was first absorbed with an equal volume of packed SRBC  to 
reduce its antibody titer still further. After incubation for 30 min at 37°C  the 
hemagglutinating titers of the absorbed (AS4) and unabsorbed (US4) sera were 
1:32  and  1:1024,  respectively.  Despite  this  loss  of  antibody,  the  absorbed 
serum remained highly active in inhibiting the induction of DTH. Mice given 
0.2  ml of AS4 intravenously  1 h  before immunization failed to develop more 
than a minor degree of DTH in response to any dose of SRBC  (Fig. 5 B). 
The unexpected findings that opsonized SRBC retained their immunogenicity 
while  serum freed  of most of its  hemagglutinating  activity still  blocked  the 
development of DTH implied that T-cell function was being obstructed by a 
product of the antigen-antibody reaction, but whether at the stage of induction 
or expression had yet to be determined. The effects of immune serum on afferent 
and efferent arms of the cellular response were therefore compared in the two 
separate experiments recorded in Fig. 6. The immune serum used for this com- 
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with an equal volume of packed SRBC. The agglutinin titers for the AS4 and 
US4 sera were 1:16 and 1:1,024, respectively. 
The effects of AS4 and US4 on the induction of DTH were tested by inject- 
ing 0.5 ml intravenously 1 day before giving the sensitizing injections of SRBC 
(108) into one hind footpad. A group of controls received an equal volume of 
normal mouse serum.  The hypersensitivity reactions elicited in the opposite 
footpad 4 days later showed that AS4 was significantly more suppressive than 
US4 (Fig. 6 A). The same two preparations were than tested for their capacity 
to interfere with the expression of an established state of hypersensitivity in 
mice which had been immunized intravenously with  105  SRBC.  On day 4, 
when DTH was at its peak (1, 2), AS4 or US4 were injected intravenously in 
doses of 0.2 ml. Controls were treated as before with serum from unimmunized 
mice. 1 h later mice of all groups, including unsensitized controls, were tested 
for hypersensitivity with an eliciting footpad injection of 108 SRBC. The reac- 
tions read 24 h later were depressed  in treated mice, especially in those given 
AS4 (Fig. 6 S). 
In that intravenously immunized mice had failed to  develop DTH and had 
shown no sign of a  lymphoproliferative response in  the popliteal lymph node 
when subsequently inoculated in the footpad with a sensitizing dose of SRBC 
(2), it was confidently expected that AS4 would have a similar inhibitory effect 
on cell proliferation and PFC production in popliteal lymph nodes. It emerged, 
however, that an intravenous injection of AS4 had almost no effect on either 
of these features of the immune response in the popliteal lymph nodes (Fig. 
7 A and D), yet caused the expected depression of DTH (Fig. 7 B). This disso- 
ciation of effects was further emphasized by the fact that the hemagglutinating 
titers on day 5 were actually increased in the pooled serum of mice treated with 
AS4 (Fig. 7 C). This increase was not due to transferred antibody because a 
separate study had shown that hemagglutinating activity was already below 
detectable levels within  1 day of injecting the  same volume of unabsorbed 
serum into normal mice. It will be noted, too, that PFC production was actu- 
ally increased in  the spleens of an  additional  group  of mice which  had re- 
ceived AS4 before immunization with 108 SRBC in both hind footpads (Fig. 7 
D). This accords with the findings of Wason (13) who found that PFC forma- 
tion by the spleen is actually increased in mice given specific  IgM antibody 
before immunization. 
Since AS4 did not interfere with the lymphoproliferative response or with 
the resulting appearance of PFC  in regionally stimulated nodes,  yet almost 
abolished the state of DTH that is a normal accompaniment of these responses, 
it was reasonable  to  conclude that AS4 must  act by blocking effector cells. 
This interpretation of the foregoing experiment assumes that helper cells are 
unaffected by AS4 while the mediators of DTH are blocked. If so, it should be 
possible to demonstrate direct inhibition of effector cells in adoptively sensi- 
tized animals. To establish this point, advantage was taken of the fact that 550  FEEDBACK  INHIBITION  OF  SENSITIZED  LYMPHOCYTES 
FIG. 4.  Cytocentrifuge preparations of peritoneal washings made 1 h after intraperitoneal 
injection of SRBC treated with  (a) normal or  (b) 4  day specific immune  serum. Leishman 
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Fro. 5.  (A) The dose-response  relationship was identical for SRBC  treated with norma 
(O  O) or specific antibody (C)---O). Both gave maximum DTH at an intravenous dose of 
105 (cf. Fig. 1). The antibody-treated cells were agglutinated, but were readily dispersed after 
washing. They remained opsonlzed, however, as shown in Fig. 4. (B) After absorption with an 
equal volume of SRBC,  the hemagglutinin  titer of 4-day immune serum fell from 1:1,024 to 
1:16.  The absorbed serum  (0.2 ml) almost completely blocked the induction of DTH at all 
antigen doses  (O---C)), whereas  normal serum  (also absorbed with SRBC)  gave a  normal 
dose-response with maximum DTH at 105 SRBC (Q  O). Means of 5 -4- SE. 
spleen cells from  cyclophosphamide-treated donors confer much  higher levels 
of  hypersensitivity  than  do  cells  obtained  from  conventionally  immunized 
donors?  In  the  experiment  recorded in  Fig.  8,  one  spleen equivalent  of cells 
was  transferred  intravenously  to  four  groups  of  recipients: A  control  group 
which received 0.2  ml of normal serum intravenously just before cell transfer 
and three test groups which were injected intravenously with AS4 (0.2 ml) at 
an interval of 24, 12, or 1 h before cell transfer. The sensitized cells were almost 
completely blocked in animals given AS4 1 h  before cell transfer, but blocking 
was  progressively less  in  animals  treated  12  and  24  h  earlier.  Apparently, 
blocking of DTH  was due  to immediate and direct inhibition of effector cells 
by a  constituent of AS4 and not  by something elaborated in recipients. This 
stands in contrast to the more slowly evolving inhibition of DTH  that results 
from  injecting excess antigen  intravenously  (2). 
DISCUSSION 
It has been apparent since methods became available for studying the cellu- 
lar kinetics of the immune response that recruitment and proliferation of pre- 
cursor cells is normally limited to a brief period of escalation before a regulatory 
2 Lagrange, P. H., G. B. Mackaness, and T. E. Miller. 1974. Potentiation of T-cell response 
by selective suppression of antibody formation with cyc]ophosphamide. Manuscript submitted 
for publication. MACKANESS,  LAGRANGE~ MILLER,  AND  ISHIBASHI 
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FIG. 6.  (A) Unabsorbed 4-day serum (US4) from mice immunized intravenously with 109 
SRBC caused partial blocking of DTH when given immediately before a sensitizing footpad 
injection of 10 s SRBC. After absorption with an equal volume of SRBC the same serum (AS4) 
blocked induction of DTH almost completely, DTH was measured 5 days after immunization. 
NS refers to recipients of normal serum absorbed with SRBC. C refers to unsensitized controls. 
Means of 5 4- SE.  (B) The same absorbed and unabsorbed serum had a  similar suppressive 
effect on previously established DTH in mice which had been sensitized 5 days earlier with 
108 SRBC in one footpad. Serum (0.2 ml) was given intravenously 1 h before the eliciting in- 
jection of SRBC (also 108). Means of 5 4- SE. 
mechanism comes into play.  If cell proliferation is a  valid criterion, it seems 
that the immune response is abruptly interrupted on the 4th day in lymph nodes 
responding to SRBC  (2). The steep rise and subsequent decay of DTH from 
its  peak  on  day 4  in  intravenously immunized  mice  also  indicates  that  an 
inhibitory mechanism is activated at this time, and that  T  cells may be the 
target  of the inhibitor.  Indeed, the  mediators of DTH are  so  susceptible  to 
inhibition that there may be no peripheral evidence of DTH to indicate that 
T  cells have  been  activated  at  all  in  intravenously immunized mice  (2  and 
Fig.  I). Since this peculiar sensitivity of intravenously immunized animals  to 
T-cell inhibition was abolished by splenectomy, it seemed that antibody must 
be implicated in the inhibitory mechanism. But whether inhibition was due to 
antibody, as such, and the site of action of the inhibitor, were important ques- 
tions that remained unanswered by the preceding study (2). They have been 
examined here and the results leave little doubt that the inhibitor is not anti- 
body alone but a product of its interaction with antigen, and that activated T 
cells are the prime target. 
The first indication came with the finding that T-cell activity, as measured by DTH, 
increased with increasing intravenous doses of SRBC until the threshold for antibody 554  FEEDBACK  INHIBITION  OF  SENSITIZED  LYMPHOCYTES 
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Fzo. 7.  (A)  Rates  of  [ZH]thymidine incorporation into DNA  by popliteal lymph nodes 
during the peak response to a footpad inoculation of l0 s SRBC, given intravenously to mice 
treated  24 h  before  sensitization with 0.2  ml  of  normal mouse  serum  (0  •  0)  or  AS4 
((D  ©). Means of 5 4- SE. (B) 24-h footpad reactions elicited on day 4 and read on day 5 
in the control (black) and AS4-treated (hatched) mice described in A. Means of 5 4- SE.  (C) 
Antibody titers (log2) in pooled, 5-day serum from mice belonging to  the groups described 
in A.  (D) Direct PFC on successive days in spleens (--) or lymph nodes  (  )  of  mice in- 
jected intravenously with 0.2 ml of normal serum (0) or AS4 (O) given 24 h before bilateral 
footpad inoculations of l0  s SRBC. Means of 5 -4- SE. 
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Fza. 8.  Effect of AS4 on DTH in mice sensitized adoptively to SRBC.  Donors  (D) were 
immunized intravenously with l0 g SRBC 2 days after an intraperitoneal injection of cyclo- 
phosphamide  (2170 mg/kg).  Spleen cells  (10 s)  were harvested 5  days later.  Recipients were 
treated intravenously with AS4 immediately (To),  12 h  (T-1/~), or 24 h  (T-l) before cell trans- 
fer. Sensitized controls received normal serum (NS). Unsensitized controls (C) received spleen 
cells from normal donors. Means of 5 4- SE. MACKANESS, LAGRANGE, MILLER, AND  ISHIBASHI  555 
production was reached (Fig.  1). When the dose of antigen was raised above this level 
hemagglutinins appeared in the serum to increasing  titer and the accompanying level 
of DTH fell proportionally, disappearing completely in animals stimulated with  108 
SRBC or more. Since the dose of antigen required to produce complete blocking of 
DTH was no more than needed to produce a maximum antibody response (10), it was 
dear that helper cell activity can proceed at a normal rate in the spleens  of intra- 
venously immunized animals without producing DTH as a  peripheral sign  that T 
cells have been activated. This raised the question of whether the mediators of DTH 
are produced at all in heavily immunized animals; but it could not be answered by cell 
transfer studies because spleen ceils from sensitive donors failed to confer hypersensi- 
tivity on anergic recipients,  and spleen cells from anergic donors were inactive when 
transferred to normal (antigen-free)  recipients.  This implied that sensitized  cells, if 
produced, were irreversibly blocked in the anergic animal. But blocking was apparently 
not due to antigen acting directly on specifically  sensitized  lymphocytes because a 
large dose of SRBC (108) had failed to suppress an existing state of DTH when given 
intravenously to animals sensitized  by footpad inoculation (2). This left three possi- 
bilities: (a) that specifically sensitized  lymphocytes are never formed, (b) are not re- 
leased, or (c) are neutralized in situ when high doses of antigen are given intravenously. 
Since the development of DTH was not suppressed by a massive intravenous dose of 
SRBC in splenectomized  mice it was logical to inquire whether reactive cells become 
trapped in the spleen. The argument against trapping as an explanation for the anergic 
state has been discussed already (2), and seems conclusive. 
The  two  remaining  possibilities  presuppose  the  existence  of  an  inhibitor 
which prevents the further induction of precursor cells and suppresses effector 
cells after they have been formed. Early serum from heavily immunized ani- 
mals did, in fact, suppress the development of DTH in response to  an optimal 
sensitizing dose of SRBC (Fig. 3), thereby suggesting that the block is situated 
early in the sequence of events leading to the production of activated T  cells. 
As blocking was more marked when immune serum was  given before rather 
than at the time of sensitization,  a passive role for antibody seemed unlikely 
because  antibody-mediated  effects  tend  to  diminish  with  time.  The  short 
half-life of immunoglobulins in mice (14,  15) dictates this tendency. Moreover, 
and  in  confirmation  of Dennert  (16),  the  antigenicity  of  SRBC  was  unim- 
paired  by opsonic  antibody  (Fig.  5 A),  but  the  serum itself  was  even more 
suppressive after partial absorption (Fig. 5 B). This made it virtually certain 
that antibody alone was not the inhibitor of activated T  cells. 
When  absorbed immune serum was injected into mice with  an established 
state of DTH it caused immediate and almost complete suppression of reactiv- 
ity (Fig. 6). This created an enigma, for it was now not clear whether animals 
fail  to  develop I)TH in  response  to  a  large primary dose  of  SRBC  because 
activated T  cells are not produced or because they are blocked by a  humoral 
factor as fast as they are formed. In an effort to answer this question,  the ki- 
netics  of the cellular response to SRBC  were studied  in  the popliteal lymph 
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caused  the  expected block to the  development  of DTH,  but  had virtually  no 
effect on the  lymphoproliferative response in nodes or on the number of PFC 
produced  therein  (Fig.  7).  Apparently,  specifically  sensitized  lymphocytes 
could be inhibited  without  affecting helper cell activity; unless,  of course,  the 
mediators  of DTH  were not produced  by serum-treated  animals,  whereas  the 
helper cells needed for a full-blown PFC response were formed in normal num- 
bers (Fig.  7). 
The idea that helper cells and the mediators of DTH  belong to different cell 
populations,  only one  of which  is produced  in  response  to  a  strong  antigenic 
stimulus,  is  inconsistent  with  the  observations  of  Kettman  (17)  who  has 
adduced  strong  circumstantial  evidence  that  the  same  thymus-derived  cells 
perform both ftmctions. Nevertheless,  blocking serum did inhibit  the adoptive 
transfer  of DTH  (Fig.  8)  without  interfering  with  antibody  formation  (Fig. 
7).  This  means  only that  the  mediators  of DTH  are  susceptible  to blocking, 
and  does  not  deny  them  an  identity  with  helper  cells.  It  is  entirely  possible 
for T  cells  to function  as helper  cells  in  one  location,  yet be prevented  from 
behaving as the mediators of DTH within the vascular compartment. 
~' Total suppression of DTH and maximum PFC production in the spleen are achieved 
with comparable doses of SRBC  (about 2-4  X  108) (2,  10,  18).  If the T  cells which 
serve as helper cells are also the mediators of DTH one function must be lost in per- 
forming the other. Without entering too deeply into the nature of helper cell function 
it is possible to examine this question and comment briefly on the possible relationship 
between helper cells and  the mediators of DTH. The former appear to function by 
surrendering up a macromolecular product that serves as a specific inducer of B  cells 
(19-21). Feldmann (20) believes that the B-cell inducer is a complex of antigen and the 
T-cell receptor, and that it needs macrophages in order to fulfill its role. Having per- 
formed this initial act of providing a specific inducer of B cells,  the responding T  cells 
are presumably free to leave the scene, enter the blood, and perform a second function 
as mediators of DTH. It is clear, however, that they may fail to do so once antibody 
production has set in, a circumstauce that clearly depends upon an adequate dose of 
antigen. Perhaps the divestment of receptors is sometimes so extreme that T  cells are 
stripped of all receptors, leaving them unable to function either as helper cells or as 
mediators of DTH. Sprent and Miller (22) have described a phenomenon which could 
be interpreted in this way. 
A  more certain consequence  of having been induced by antigen is for T  cells 
to  transform  and  divide  (23).  It  is  by no  means  clear  at  what  stage  in  this 
sequence of events that responding T  cells become capable of mediating DTH 
reactions,  or  what  relationship  the  mediators  of hypersensitivity  bear  to the 
memory  cells  that  are  created  at  the  same  time.  Coe  and  Salvin  (24)  have 
shown, however,  that guinea pigs which develop I)TH in response to a minute 
dose  of  antigen  may  have  no  detectable  antibodies  in  circulation  but  are 
primed  to give a  secondary  antibody  response.  The  appearance  of antibodies 
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This points again to the reality of a T-cell blocking mechanism that depends 
not on antigen or antibody, but on a product of the two. This dual requirement 
explains the apparent discrepancy between the present findings and those of 
Axelrad (25)  who observed that an existing state of DTH can be suppressed 
by a subcutaneous or intraperitoneal injection of antigen alone. Axelrad used 
Freund's complete adjuvant and waited 9  days before injecting the desensi- 
tizing  dose  of  antigen.  At  this  time  circulating  antibodies  were  present  to 
high titer. In the present studies, a modest dose of SRBC was inoculated into 
the footpad, and antibodies were low or absent on day 4 when desensitization 
was attempted. If blocking is due to interaction between antigen and antibody, 
antigen injected at this time would not encounter the  antibodies needed for 
the formation of blocking factors and should not cause desensitization. This 
view is consistent with the findings (2),  and gains support from Axelrad's own 
observation that the desensitizing effects of antigen and antibody were  syner- 
gistic. 
Similar reasoning may be used to explain why spleen cells of spontaneously 
anergic mice failed to transfer sensitivity to recipients (Fig. 2), whereas Dwyer 
and Kantor  (9)  succeeded in transferring DTH with peripheral  lymph node 
cells of guinea pigs which had been actively desensitized by injections of anti- 
gen. Here the difference lies  not in the absence of proper  conditions for the 
creation of blocking factors, but in the accessibilities of the cells  chosen  for 
transfer to the blocking factors that accumulate in serum. There is,  in fact, 
precedent  for  believing  that  functionally active  cells  may be  found in  one 
location but not in another (26).  Blocking factors which can interfere with the 
mediators of DTH in spleen and blood but not in peripheral lymphoid tissue 
are likely to be macromolecules that are mainly confined to the blood. There 
is, of course, substantial evidence to suggest that antigen-antibody complexes 
can  interfere  with the function of  lymphocytes. Diener  and  Feldmann (12) 
showed  that  immune complexes,  formed in  antibody excess,  act  rapidly  to 
suppress  an antibody response in vitro. As tolerance is difficult to induce in 
vitro, except to T-cell-independent antigens (27),  it seems that this example 
of inhibition by immune complexes involves suppression of B  cells.  There is 
little doubt, however, that immune complexes can also interfere with the per- 
formance of T  cells. The Hellstr6ms (28) have made observations which sug- 
gest that lymphocyte-mediated destruction of target cells  can be blocked by 
immune complexes in vitro, but it has not been established whether  effector 
cell  or target cell  is affected in this system. The present studies provide in- 
ferential evidence that the blocking factors that inhibit the mediators of DTH 
act directly on the effector cells. A mechanism whereby this effect of immune 
complexes,  if such they are,  inhibit the mediators of DTH may be  deduced 
from the findings of Yoshida and Andersson (29)  who have shown that acti- 
vated T  cells can bind antigen-IgG complexes.  The present studies hint at the 
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functionally suppressed as a  consequence.  The present  studies  have not pro- 
vided any evidence,  however, concerning  the identity of the  blocking factors 
that appear in the serum of anergic mice. 
SUMMARY 
An  explanation was sought for the fact that delayed-type hypersensitivity 
(DTH)  does  not  normally  occur  in  response  to  T-cell-dependent  antigens 
unless  an  adjuvant  is  used.  But  when  sheep  red  blood  cells  (SRBC)  were 
administered intravenously DTH did appear, provided that the dose of antigen 
was less than that required to give a maximum antibody response. Animals in 
which T-cell activity had been blocked by a large dose of antigen could not be 
sensitized adoptively, and their spleen cells failed to transfer DTH to normal 
recipients.  The serum of blocked animals partially inhibited  the induction  of 
DTH,  and  after absorption  with  SRBC  its  blocking  activity increased  sub- 
stantially.  Moreover, absorbed serum inhibited DTH in previously sensitized 
animals, but it did not inhibit the proliferative response to SRBC in peripheral 
lymph nodes or reduce  the number of plaque-forming cells produced  therein. 
On the contrary,  the hemagglutinating titer was actually increased by block- 
ing  serum  even  though  DTH  was  totally suppressed.  It is  concluded  that  a 
product of the interaction between antigens and antibody blocks the activated T 
cells which mediate DTH without interfering with helper cells. 
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